Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters











Database
Language
Publication year range
1.
Bioorg Med Chem ; 22(22): 6490-6502, 2014 Nov 15.
Article in English | MEDLINE | ID: mdl-25440730

ABSTRACT

Polyomavirus infections are common and relatively benign in the general human population but can become pathogenic in immunosuppressed patients. Because most treatments for polyomavirusassociated diseases nonspecifically target DNA replication, existing treatments for polyomavirus infection possess undesirable side effects. However, all polyomaviruses express Large Tumor Antigen (T Ag), which is unique to this virus family and may serve as a therapeutic target. Previous screening of pyrimidinone­peptoid hybrid compounds identified MAL2-11B and a MAL2-11B tetrazole derivative as inhibitors of viral replication and T Ag ATPase activity (IC50 of ~20-50 µM. To improve upon this scaffold and to develop a structure­activity relationship for this new class of antiviral agents, several iterative series of MAL2-11B derivatives were synthesized. The replacement of a flexible methylene chain linker with a benzyl group or, alternatively, the addition of an ortho-methyl substituent on the biphenyl side chain in MAL2-11B yielded an IC50 of 50 µM, which retained antiviral activity. After combining both structural motifs, a new lead compound was identified that inhibited T Ag ATPase activity with an IC50 of 50 µM. We suggest that the knowledge gained from the structure­activity relationship and a further refinement cycle of the MAL2-11B scaffold will provide a specific, novel therapeutic treatment option for polyomavirus infections and their associated diseases.


Subject(s)
Antigens, Viral, Tumor/chemistry , Antiviral Agents/chemical synthesis , Simian virus 40/metabolism , Small Molecule Libraries/chemistry , Antigens, Viral, Tumor/metabolism , Antiviral Agents/pharmacology , Antiviral Agents/toxicity , Cell Survival/drug effects , HEK293 Cells , Humans , Peptoids/chemistry , Polyomavirus/drug effects , Protein Binding , Pyrimidinones/chemistry , Small Molecule Libraries/chemical synthesis , Small Molecule Libraries/pharmacology , Structure-Activity Relationship , Virus Replication/drug effects
2.
Antiviral Res ; 96(1): 70-81, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22898086

ABSTRACT

New polyomaviruses are continually being identified, and it is likely that links between this virus family and disease will continue to emerge. Unfortunately, a specific treatment for polyomavirus-associated disease is lacking. Because polyomaviruses express large Tumor Antigen, TAg, we hypothesized that small molecule inhibitors of the essential ATPase activity of TAg would inhibit viral replication. Using a new screening platform, we identified inhibitors of TAg's ATPase activity. Lead compounds were moved into a secondary assay, and ultimately two FDA approved compounds, bithionol and hexachlorophene, were identified as the most potent TAg inhibitors known to date. Both compounds inhibited Simian Virus 40 replication as assessed by plaque assay and quantitative PCR. Moreover, these compounds inhibited BK virus, which causes BKV Associated Nephropathy. In neither case was host cell viability compromised at these concentrations. Our data indicate that directed screening for TAg inhibitors is a viable method to identify polyomavirus inhibitors, and that bithionol and hexachlorophene represent lead compounds that may be further modified and/or ultimately used to combat diseases associated with polyomavirus infection.


Subject(s)
Adenosine Triphosphatases/antagonists & inhibitors , Antigens, Viral, Tumor/metabolism , Antiviral Agents/pharmacology , BK Virus/drug effects , Enzyme Inhibitors/pharmacology , Simian virus 40/drug effects , Virus Replication/drug effects , Antiviral Agents/isolation & purification , BK Virus/enzymology , BK Virus/physiology , Drug Evaluation, Preclinical/methods , Enzyme Inhibitors/isolation & purification , Humans , Real-Time Polymerase Chain Reaction , Simian virus 40/enzymology , Simian virus 40/physiology , Viral Plaque Assay
3.
Ecology ; 92(1): 11-8, 2011 Jan.
Article in English | MEDLINE | ID: mdl-21560671

ABSTRACT

The coming century is predicted to feature enhanced climatic variability, including increased frequency, intensity, and duration of extreme climatic events. Ecologists are faced with the critical challenge of anticipating potentially nonlinear ecosystem responses to these changes. High-resolution paleoecological data sets that capture past ecosystem responses to climate variability provide valuable long-term perspectives on the sensitivity of ecosystems to climate-forced state shifts. We used a suite of paleoecological analyses at Titus Bog in northwestern Pennsylvania, USA, to test the hypothesis that the development and expansion of floating peatlands in kettlehole basins represents a threshold response to hydroclimate variability. In contrast with expectations of gradual autogenic peat mat expansion, our results indicate that peat mat expansion at Titus Bog was highly episodic and occurred in three distinct pulses centered on 800, 650, and 400 cal yr BP. Each of these expansion events coincided with or immediately followed decadal-to-mutlidecadal droughts recorded in regional paleoclimate reconstructions. These patterns indicate that peatland development in kettlehole basins can follow nonlinear trajectories, with episodes of rapid advancement triggered by climatic forcing. Future climate changes may increase the likelihood of peatland expansion in kettlehole basins, potentially leading to abrupt changes in adjacent lake ecosystems.


Subject(s)
Soil , Wetlands , Animals , Pennsylvania , Time Factors
4.
Proc Natl Acad Sci U S A ; 108(17): 6757-62, 2011 Apr 26.
Article in English | MEDLINE | ID: mdl-21502524

ABSTRACT

Unique chemical methodology enables the synthesis of innovative and diverse scaffolds and chemotypes and allows access to previously unexplored "chemical space." Compound collections based on such new synthetic methods can provide small-molecule probes of proteins and/or pathways whose functions are not fully understood. We describe the identification, characterization, and evolution of two such probes. In one example, a pathway-based screen for DNA damage checkpoint inhibitors identified a compound, MARPIN (ATM and ATR pathway inhibitor) that sensitizes p53-deficient cells to DNA-damaging agents. Modification of the small molecule and generation of an immobilized probe were used to selectively bind putative protein target(s) responsible for the observed activity. The second example describes a focused library approach that relied on tandem multicomponent reaction methodologies to afford a series of modulators of the heat shock protein 70 (Hsp70) molecular chaperone. The synthesis of libraries based on the structure of MAL3-101 generated a collection of chemotypes, each modulating Hsp70 function, but exhibiting divergent pharmacological activities. For example, probes that compromise the replication of a disease-associated polyomavirus were identified. These projects highlight the importance of chemical methodology development as a source of small-molecule probes and as a drug discovery starting point.


Subject(s)
Drug Design , HSP70 Heat-Shock Proteins/antagonists & inhibitors , Molecular Probes , Ataxia Telangiectasia Mutated Proteins , Cell Cycle Proteins/metabolism , Cell Line , DNA-Binding Proteins/metabolism , HSP70 Heat-Shock Proteins/metabolism , Humans , Molecular Probes/chemical synthesis , Molecular Probes/chemistry , Molecular Probes/pharmacology , Polyomavirus/physiology , Polyomavirus Infections/drug therapy , Polyomavirus Infections/metabolism , Protein Serine-Threonine Kinases/metabolism , Signal Transduction/drug effects , Tumor Suppressor Proteins/metabolism , Virus Replication/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL